Abstract
To more effectively drive immune responses toward antigen-specific T helper type 2 (Th2) cellmediated responses, we constructed a mammalian expression vector (pOVA/IL4) carrying a fused gene in which the ovalbumin (OVA) cDNA was covalently linked to murine interleukin-4 (IL-4) cDNA. A biologically active OVA/IL4 protein was expressed by the transfected COS cells with the pOVA/IL4 DNA, as demonstrated by Western blotting and cytokine bioassay. Intramuscular injection of BALB/c mice with the pOVA/IL4 DNA increased both the production of OVA-specific IL-4 by CD4+ T cells and the ratio of anti-OVA IgG1 to anti-OVA IgG2a isotypes, while the injection with the pOVA DNA alone, or with the mixture of the pOVA and plL4 DNA did no or little increase. Furthermore, the OVA-specific, Th2 cell-mediated immune responses were significantly enhanced by multiple injections with the pOVA/IL4 DNA. These studies indicate that the direct linkage of an OVA gene to an IL-4 gene in the expression plasmid confines the effects of IL-4 to the OVA-specific cells, efficiently driving the immune response toward OVA-specific., Th2 cell-mediated responses.
Similar content being viewed by others
References Cited
Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevvach, E. M. and Strober, W.,Current Protocols in Immunology. John Wiley & Sons, New York, 1995.
Constant, S. L. and Bottomly, K., Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.Annu. Rev. Immunol., 15, 297–322 (1997).
Danko, I. and Wolff, J. A., Direct gene transfer into muscle.Vaccine, 12, 1499–1502 (1994).
DeKruyff, R. H., Fang, Y., Wolf, S. F. and Umetsu, D. T., IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells.J. Immunol., 154, 2578–2587 (1995).
Gilboa, E., Immunotherapy of cancer with genetically modified tumor vaccines.Semin. Oncol., 23, 101–107 (1996).
Gillies, S. D., Young, D., Lo, K. M. and Roberts, S., Biological activity andin vivo clearance of antitumor antibody/cytokine fusion proteins.Bioconj. Chem., 4, 230–235 (1993).
Gross, A., Ben-Sasson, Z. and Paul, W. E., Anti-IL-4 diminishesin vivo priming for antigen-specific IL-4 production by T cells.J. Immunol., 150, 2112–2120 (1993).
Kim, T. S., DeKruyff, R. H., Rupper, R., Maecker, H. T., Levy, S. and Umetsu, D. T., An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus recombinant IL-12 in inducing a T helper cell type 1-dominanted immune response and inhibiting antigen-specific IgE production.J. Immunol., 158, 4137–4144 (1997).
Lim, Y. S., Kang, B. Y., Kim, E. J., Kim, S. H., Hwang, S. Y. and Kim, T. S., Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-γ hybrid construct.Immunol., 94, 135–141 (1998).
Mosmann, T. R., Schumacher, J. H., Street, N. F., Budd, R., O'Garra, A., Fong, T. A., Bond, M. W., Moore, K. W., Sher, A. and Fiorentino, D. F., Diversity of cytokine synthesis and function of mouse CD4+ T cells.Immunol. Rev., 123, 209–229 (1991).
Openshaw, P., Murphy, E., Hosken, N. A., Maino, Y., Davis, K., Murphy, K. and O'Garra, A., Heterogenicity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and helper 2 populations.J. Exp. Med., 182, 1357–1367 (1995).
Pertmer, T. M., Roberts, T. R. and Haynes, J. R., Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.J. Virol., 70, 6119–6125 (1996).
Reff, M. E., Garner, K., Chambers, K. S., Chinn, P. C., Leonard, J. E., Raab, R., Newman, R. A., Hanna, N. and Anderson, D. R., Depletion of B cellsin vivo by chimeric mouse human monoclonal antibody to CD20.Blood, 83, 435–445 (1994).
Romagnani, S., Th1 and Th2 in human diseases.Clin. Immunol. Immunopathol., 80, 225–235 (1996a).
Romagnani, S., Development of Th1- or Th2-dominated immune responses: what about the polarizing signals?Int. J. Clin. Res., 26, 83–98 (1996b).
Romagnani, S., Parronchi, P., D'Elio, M. M., Romagnani, P., Annunziato, F., Piccinni, M. P., Manetti, R., Sampognaro, S., Mavilia, C., De Carli, M., Maggi, E. and Del Prete, G. F., An update on human Th1 and Th2 cells.Int. Arch. Allergy. Immunol., 113, 153–156 (1997).
Wang, B., Ugen, K. E., Srikantan, V., Agadianyan, M. G., Dang, K., Refaeli, Y., Sato, A. I., Boyer, J., Williams, W. V. and Weiner, D. B., Gene inoculation generates immune responses against human immunodeficiency virus type 1.Proc. Natl. Acad. Sci. USA, 90, 4156–4160 (1993).
Wells, D. J., Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle.FEBS Lett., 332, 179–182 (1993).
Whitton, J. L. and Yokoyama, M., Proteins expressed by DNA vaccines induce both local and systemic immune responses.Ann. NY Acad. Sci., 797, 196–206 (1996).
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsaoi, G., Jani, A. and Felgner, P. L., Direct gene transfer into mouse musclein vivo.Science, 247, 1465–1468 (1990).
Yokoyama, M., Hassett, D. E., Zhang, J. and Whitton, J. L., DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site.Vaccine, 15, 553–560 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lim, Y.S., Kang, B.Y., Kim, E.J. et al. Vaccination with an ovalbumin/interleukin-4 fusion DNA efficiently induces Th2 cell-mediated immune responses in an ovalbumin-specific manner. Arch. Pharm. Res. 21, 537–542 (1998). https://doi.org/10.1007/BF02975371
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02975371